STERIS plc
STE
Classificação em ações
#1071
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Preço da ação
$222.31
Última sincronização: 2026-10-19
Valor de mercado
$21.68B
Variação (1 dia)
0.06%
Variação (1 ano)
-8.22%
País
IE
Negociar STERIS plc (STE)
Categoria
Healthcare
Rácio P/E de STERIS plc (STE)
Rácio P/E em October 2026 TTM: 26.50
De acordo com os últimos relatórios financeiros e o preço das ações da STERIS plc, o rácio P/E atual (TTM) é 26.50. No final de 2024, a empresa tinha um P/E de 57.73.
Histórico do rácio P/E da STERIS plc de 2000 a 2026
Rácio P/E no final de cada ano
| Ano | Índice P/E | Alterar |
|---|---|---|
| 2026 (TTM) | 26.50 | -27.11% |
| 2025 | 36.35 | -37.03% |
| 2024 | 57.73 | -67.60% |
| 2023 | 178.19 | 84.29% |
| 2022 | 96.69 | 136.75% |
| 2021 | 40.84 | 40.30% |
| 2020 | 29.11 | -17.88% |
| 2019 | 35.45 | 29.90% |
| 2018 | 27.29 | -49.46% |
| 2017 | 53.99 | 19.05% |
| 2016 | 45.35 | 46.71% |
| 2015 | 30.91 | 42.11% |
| 2014 | 21.75 | 45.00% |
| 2013 | 15.00 | 10.64% |
| 2012 | 13.56 | -66.07% |
| 2011 | 39.96 | 159.24% |
| 2010 | 15.41 | 24.68% |
| 2009 | 12.36 | -43.79% |
| 2008 | 21.99 | 4.33% |
| 2007 | 21.08 | -12.03% |
| 2006 | 23.96 | 17.67% |
| 2005 | 20.36 | 7.34% |
| 2004 | 18.97 | -17.33% |
| 2003 | 22.95 | -27.34% |
| 2002 | 31.58 | -95.52% |
| 2001 | 705.00 | 1,000.49% |
| 2000 | 64.06 | 0.00% |
Rácio P/E para empresas semelhantes ou concorrentes
| Empresa | Rácio P/E | Diferença do rácio P/E | País |
|---|---|---|---|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| - | - |
DE
|
Como interpretar um P/E Ratio?
O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.
Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.
Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.